PENOBSCOT INVESTMENT MANAGEMENT COMPANY, INC. – Regeneron Pharmaceuticals, Inc. Transaction History
PENOBSCOT INVESTMENT MANAGEMENT COMPANY, INC. portfolio value:
$723,000
portfolio value
PENOBSCOT INVESTMENT MANAGEMENT COMPANY, INC. quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 103K | $688.87 | 1.04K | |
| Q2 2022 | share | 0.00% | 0 shares | -113K | $591.13 | 1.04K | |
| Q1 2022 | share | 0.00% | 0 shares | 71K | $698.42 | 1.04K | |
| Q4 2021 | share | Increase | +13.41% | 124 shares | 102K | $642.51 | 1.04K |
| Q3 2021 | share | 0.00% | 0 shares | 43K | $605.18 | 925 | |
| Q2 2021 | share | Increase | +37.04% | 250 shares | 198K | $558.54 | 925 |
| Q1 2021 | share | 0.00% | 0 shares | -7K | $473.14 | 675 | |
| Q4 2020 | share | 0.00% | 0 shares | -52K | $483.11 | 675 | |
| Q3 2020 | share | Decrease | -15.63% | -125 shares | -121K | $559.78 | 675 |
| Q2 2020 | share | 0.00% | 0 shares | 108K | $623.65 | 800 | |
| Q1 2020 | share | 0.00% | 0 shares | 91K | $488.29 | 800 | |
| Q4 2019 | share | 0.00% | 0 shares | 78K | $375.48 | 800 | |
| Q3 2019 | share | 0.00% | 0 shares | -28K | $277.4 | 800 | |
| Q2 2019 | share | 0.00% | 0 shares | -78K | $313 | 800 | |
| Q1 2019 | share | 0.00% | 0 shares | 29K | $410.62 | 800 | |
| Q4 2018 | share | Increase | +14.29% | 100 shares | 16K | $373.5 | 800 |
| Q3 2018 | share | 0.00% | 0 shares | 42K | $404.04 | 700 | |
| Q2 2018 | share | 0.00% | 0 shares | 0 | $344.99 | 700 | |
| Q1 2018 | share | 0.00% | 0 shares | -22K | $344.36 | 700 | |
| Q4 2017 | share | 0.00% | 0 shares | -50K | $375.96 | 700 | |
| Q3 2017 | share | 0.00% | 0 shares | -31K | $447.12 | 700 | |
| Q2 2017 | share | 0.00% | 0 shares | 73K | $491.14 | 700 | |
| Q1 2017 | share | 0.00% | 0 shares | 14K | $387.51 | 700 | |
| Q4 2016 | share | 0.00% | 0 shares | -24K | $367.09 | 700 | |
| Q3 2016 | share | 0.00% | 0 shares | 37K | $402.02 | 700 | |
| Q2 2016 | share | 0.00% | 0 shares | -8K | $349.23 | 700 | |
| Q1 2016 | share | 0.00% | 0 shares | -128K | $360.44 | 700 |